Market Research Logo

Prostate Cancer Therapeutics Market, by Drug Type, Distribution Channel, and Geography - Global Trends, and Forecast to 2025

Prostate Cancer Therapeutics Market, by Drug Type, Distribution Channel, and Geography - Global Trends, and Forecast to 2025

Prostate cancer is the most common cancer among the geriatric male population. It is a major health concern, especially in developed countries with a greater proportion of elderly men being affected by it. According to European Association of Urology, 2016, the incidence is highest in Northern and Western Europe (> 200 per 100,000 men with age group > 70 years of age), while rates in Eastern and Southern Europe have showed a continuous increase. Thus, the introduction of innovative drugs for patients with prostate cancer is required to meet the unmet needs with satisfactory results. Currently, metastatic castration-resistant prostate cancer (CRPC) is usually treated with chemotherapy (docetaxel, and cabazitaxel) or secondary hormonal therapeutic agents such as abiraterone or Triptorelin. Immunotherapy with Sipuleucel-T is prescribed in treating asymptomatic or minimally metastatic CRPC without visceral metastasis.
Market Dynamics
The market is gaining significant traction due to continuous investment by research organizations and universities for the development of therapeutic products for the treatment of such tumors. Novel therapies are expected to be predominately approved in castration-resistant patients, and to compete with better-established treatments, such as Zytiga, Xtandi and generic docetaxel, or to act as adjuvants to established therapies. For instance, there is a strong pipeline of products such as Metformin (Mansoura University), Avelumab (Duke University Medical Center), LY2452473 (Dana-Farber Cancer Institute), which are in their phase 2 studies and are projected to enter the market in the near future. However, high cost and side effects associated with drugs can restraint the market growth.
Key features of the study:

This report provides in-depth analysis of the prostate cancer therapeutics market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2016 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global prostate cancer therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Johnson & Johnson, Astella, Inc, Sanofi-Aventis, Bayer AG, AstraZeneca Plc, Pfizer Inc., Dendreon Corporation (Sanpower Group Co. Ltd.), Ipsen Group, Tolmar Inc, Endo Pharmaceuticals, AbbVie, Inc.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.
The global prostate cancer therapeutics market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for prostate cancer therapeutics market, research and consulting firms, new entrants and financial analysts
Various strategy matrices used in analyzing the prostate cancer therapeutics market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

Global Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Global Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Global Prostate Cancer Therapeutics Market, By Geography:

North America

U.S.

U.S. Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

U.S. Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Canada

Canada Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Canada Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Europe

U.K.

U.K. Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

U.K. Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Germany

Germany Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Germany Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Italy

Italy Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Italy Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

France

France Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

France Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Spain

Spain Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Spain Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Russia

Russia Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Russia Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Rest of Europe

Rest of Europe Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Rest of Europe Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Asia-Pacific

China

China Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

India

India Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

India Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Japan

Japan Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Japan Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

ASEAN

ASEAN Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

ASEAN Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Australia

Australia Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Australia Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

South Korea

South Korea Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

South Korea Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Rest of Asia Pacific

Rest of Asia Pacific Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Rest of Asia Pacific Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Latin America

Brazil

Brazil Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Brazil Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Mexico

Mexico Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Mexico Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Rest of Latin America

Rest of Latin America Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Rest of Latin America Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Middle East

GCC

GCC Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

GCC Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Israel

Israel Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Israel Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Rest of Middle East

Rest of Middle East Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Rest of Middle East Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Africa

North Africa

North Africa Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

North Africa Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Central Africa

Central Africa Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

Central Africa Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

South Africa

South Africa Prostate Cancer Therapeutics Market, By Drug Type:

Hormonal Therapy

Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist

Abiraterone Acetate (Zytiga)
Degarelix Acetate (Firmagon/Gonax)

Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Goserelin Acetate (Zoladex)
Leuprorelin acetate (Prostap or Lutrate)
Triptorelin (Trelstar)
Others

Anti-Androgens

Enzalutamide (Xtandi)
Nilutamide (Nilandron)
Others

Immunotherapy

Sipuleucel-T (Provenge)

Targeted Therapy

Radium 223 Dichloride (Xofigo)

Chemotherapy

Cabazitaxel (Jevtana)
Docetaxel (Taxotere)

South Africa Prostate Cancer Therapeutics Market, By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Company Profiles

Johnson & Johnson

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans

Astellas Pharma Inc.
AstraZeneca Plc
Sanofi
Bayer AG
Pfizer, Inc.
Dendreon Corporation (Sanpower Group Co. Ltd.)
Ipsen Group
Tolmar Inc.
Endo International plc
AbbVie, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Regulatory Scenario
Reimbursement Scenario
Pipeline Analysis
PEST Analysis
PORTER’S Five Forces
4. Global Prostate Cancer Therapeutics Market, By Drug Type, 2017 - 2025, (US$ Million)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017 - 2025
Segment Trends
Hormonal Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Luteinizing Hormone-Releasing Hormone (LHRH) Antagonist
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Abiraterone Acetate (Zytiga)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Degarelix Acetate (Firmagon/Gonax)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Luteinizing Hormone-Releasing Hormone (LHRH) Agonist
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Goserelin Acetate (Zoladex)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Leuprorelin Acetate (Prostap or Lutrate)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Triptorelin (Trelstar)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Anti-Androgens
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Enzalutamide (Xtandi)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Nilutamide (Nilandron)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Sipuleucel-T (Provenge)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Targeted Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Radium 223 Dichloride (Xofigo)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Chemotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Cabazitaxel (Jevtana)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Docetaxel (Taxotere)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
5. Global Prostate Cancer Therapeutics Market, By Distribution Channel, 2017 - 2025, (US$ Million)
Introduction
Market Share Analysis, 2016 and 2025 (%)
Y-o-Y Growth Analysis, 2017 - 2025
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
6. Global Prostate Cancer Therapeutics Market, By Region, 2017 - 2025, (US$ Million)
Introduction
Market Share Analysis, By Region, 2016 and 2025 (%)
Y-o-Y Growth Analysis, By Region, 2017 - 2025
North America
Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
Brazil
Mexico
Rest of Latin America
Africa
Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
Northern Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Drug Type, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Distribution Channel, 2017 - 2025, (US$ Million)
Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
GCC Countries
Israel
Rest of Middle East
7. Competitive Landscape
Heat Map Analysis
Company Profiles
Johnson & Johnson
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Astellas Pharma, Inc
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Sanofi
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Bayer AG
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
AstraZeneca Plc
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Pfizer, Inc.
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Dendreon Corporation (Sanpower Group Co. Ltd.)
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Ipsen Group
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Tolmar Inc
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Endo International plc
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
AbbVie, Inc.
Company Overview
Technology Portfolio
Financial Performance
Recent Developments/Updates
Strategies
8. Section
Analyst Views
Research Methodology
About Us and Sales Contact
*Browse 29 market data tables and 33 figures on "Prostate Cancer Therapeutics Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report